시노펙스

025320KOSDAQ전자부품 제조업

52.3 / 100

Reference Date: 2026-04-13

Financial Score13.5 / 40

News Sentiment19.8 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but PER raises overvaluation concerns. Slightly up 1.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Sinopex leverages its expertise in nanotechnology and materials to provide innovative solutions in FPCB (Flexible Printed Circuit Board) and filtration sectors, supplying products across electronics and environmental industries. The FPCB business unit, operating through a global production network, accounts for over 89% of revenue, while the filtration division contributes 11% through environmental and industrial filtration solutions.

Number of Employees

162people

Average Salary

69.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

74.50Industry Average 21.840.0Point

3.4x industry avg (risky)

PBR

—Industry Average 1.233.5Point

ROE

4.22Industry Average 4.682.5Point

Below industry avg

Debt Ratio

10.50Industry Average 10.874.0Point

In line with industry avg

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼40.2% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 11.7% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 4Neutral 1Negative 0Average Sentiment Score 85

Positive
시노펙스, 서울대학교 병원에 혈액여과기 공식 공급
시노펙스는 국내 최초로 국산화에 성공한 혈액여과기 '시노플럭스'를 서울대학교 병원에 공식 공급하며 국내 최고 수준의 의료 현장에 진입했습니다.
Positive
"서울대병원 뚫었다" 시노펙스, 혈액여과기 사용 착수
시노펙스의 혈액여과기 '시노플럭스'가 서울대병원을 포함한 국내 8개 상급 종합병원에 정식 사용 제품으로 등록되어 공급 확대가 기대됩니다.
Positive
시노펙스, ‘KIMES 2026’서 국산 이동형 혈액투석 솔루션 공개…...
시노펙스는 'KIMES 2026'에 참가하여 범부처의료기기연구개발사업단(KMDF)이 주관하는 국책과제 성과 홍보관에 대표 기업으로 초청되어 이동형 혈액투석 관련 통합 솔루션을 선보였습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 5,960Won52-week high 7,99052-week low 5,400

1-month return3.0Point

1m 1.02% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral정기주주총회결과2026-03-26
Neutral[첨부정정]사업보고서 (2025.12)2026-03-19
Neutral[첨부정정]사업보고서 (2025.12)2026-03-19
Neutral사업보고서 (2025.12)2026-03-18
Neutral감사보고서제출2026-03-18